E-mail Print PDF

Phase III study which is a randomized, double blind, placebo controlled, parallel group study to evaluate the effect of study drug on the occurrence of CV events in patients who have recently experience an ACS (EFC11570) Drug SAR236553

Status : Ongoing

Sponsor: Sanofi-Aventis (Malaysia) Sdn Bhd

Duration : 2013 - 2018

Principal investigator : Prof. Dato' Dr. Khalid Yusoff and Associate Prof. Dr. Sazzli Kasim

Co-Investigator/s : Dr. Effarezan Abd Rahman, Dr. Hafisyatul Aiza and Dr. Johan Rizwal Ismail

Study Manager : Noor Amanina Shaharudin and Nuaim Hussin

Study Member : Syuhaida Sulaiman, Zainol Ariffin Mohammad, Siti Masnirah Alwi, Syumaimah Muhamad Yunus and Najmin Abu Bakar

Venue : CenTRE, UiTM Selayang Campus and Sungai Buloh Campus

TOOLS for the researcher

  • Clinical research/trial development
  • Statisticians to consult on study design and analysis
  • Facilitate proposal  submission process
  • Study coordinators
  • Subject recruitment registry
  • Collaboration with Clinical Research Organizations (CRO)s

FACILITIES for the researcher

  • Consultation rooms
  • Day care centre
  • Patient monitoring
  • Satellite pharmacy
  • On site radiological imaging and specialised tests in various subspecialties eg cardiology, respiratory medicine, gastroenterology
  • Archiving and storage


The CenTRE conducts various teaching and training programmes to educate and train researchers in translational research and epidemiology, enabling them to conduct high quality research. This can be in the form of seminars, lectures, workshops or short courses. Read more...

Visitors Counter

Number of visitors since 2010
mod_vvisit_counterThis week496
mod_vvisit_counterThis month6061

Today: Dec 18, 2017

Take a survey

How did you hear about Us ?


Staff News

Note Headline.